Anales RANF

Nannocannabinoids for brain tumor drug delivery @Real Academia Nacional de Farmacia. Spain 213 44. Aparicio-Blanco J, Martin-Sabroso C, Torres-Suarez AI. In vitro screening of nanomedicines through the blood brain barrier: A critical review. Biomaterials. 2016;103:229-55. 45. Morales D, Gutierrez JM, Garcia-Celma MJ, Solans YC. A study of the relation between bicontinuous microemulsions and oil/water nano-emulsion formation. Langmuir. 2003;19:7196-200. 46. Izquierdo P, Esquena J, Tadros TF, Dederen JC, Feng J, Garcia-Celma MJ, et al. Phase behavior and nano- emulsion formation by the phase inversion temperature method. Langmuir. 2004;20:6594-8. 47. Anton N, Vandamme TF. The universality of low- energy nano-emulsification. International Journal of Pharmaceutics. 2009;377:142-7. 48. Chuesiang P, Siripatrawan U, Sanguandeekul R, McLandsborough L, McClements DJ. Optimization of cinnamon oil nanoemulsions using phase inversion temperature method: Impact of oil phase composition and surfactant concentration. Journal of Colloid and Interface Science. 2018;514:208-16. 49. Sadurni N, Solans C, Azemar N, Garcia-Celma MJ. Studies on the formation of O/W nano-emulsions, by low-energy emulsification methods, suitable for pharmaceutical applications. European Journal of Pharmaceutical Sciences. 2005;26:438-45. 50. Caldero G, Garcia-Celma MJ, Solans C. Formation of polymeric nano-emulsions by a low-energy method and their use for nanoparticle preparation. Journal of Colloid and Interface Science. 2011;353:406-11. 51. Morral-Ruiz G, Melgar-Lesmes P, Garcia ML, Solans C, Garcia-Celma MJ. Polyurethane and polyurea nanoparticles based on polyoxyethylene castor oil derivative surfactant suitable for endovascular applications. International Journal of Pharmaceutics. 2014;461:1-13. 52. Elgammal M, Schneider R, Gradzielski M. Preparation of latex nanoparticles using nanoemulsions obtained by the phase inversion composition (PIC) method and their application in textile printing. Colloids and Surfaces a- Physicochemical and Engineering Aspects. 2015;470:70-9. 53. Balzeau J, Pinier M, Berges R, Saulnier P, Benoit JP, Eyer J. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells. Biomaterials. 2013;34:3381-9. 54. Gaillard PJ, Appeldoorn CCM, Dorland R, van Kregten J, Manca F, Vugts DJ, et al. Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101). Plos One. 2014;9:e82331. 55. Bih CI, Chen T, Nunn AVW, Bazelot M, Dallas M, Whalley BJ. Molecular Targets of Cannabidiol in Neurological Disorders. Neurotherapeutics. 2015;12:699-730. 56. Belhadj Z, Ying M, Cao X, Hu XF, Zhan CY, Wei XL, et al. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Journal of Controlled Release. 2017;255:132-41. 57. Luo ZM, Yan ZQ, Jin K, Pang Q, Jiang T, Lu H, et al. Precise glioblastoma targeting by AS1411 aptamer- functionalized poly (L-gamma-glutamylglutamine)- paclitaxel nanoconjugates. Journal of Colloid and Interface Science. 2017;490:783-96. 58. Luo ZM, Jin K, Pang Q, Shen S, Yan ZQ, Jiang T, et al. On-Demand Drug Release from Dual-Targeting Small Nanoparticles Triggered by High-Intensity Focused Ultrasound Enhanced Glioblastoma- Targeting Therapy. Acs Applied Materials & Interfaces. 2017;9:31612-25. 59. Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. Journal of Controlled Release. 2010;141:183-92. 60. Wei L, Guo XY, Yang T, Yu MZ, Chen DW, Wang JC. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core- shell nanoparticles. International Journal of Pharmaceutics. 2016;510:394-405. 61. Holgado MA, Martin-Banderas L, Alvarez-Fuentes J, Fernandez-Arevalo M. Neuroprotective effect of cannabinoids nanoplatforms in neurodegenerative diseases. Journal of Drug Delivery Science and Technology. 2017;42:84-93. 62. Chen CT, Duan ZQ, Yuan Y, Li RX, Pang L, Liang JM, et al. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. Acs Applied Materials & Interfaces. 2017;9:5864-73. 63. Wei XL, Gao J, Zhan CY, Xie C, Chai ZL, Ran D, et al. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Journal of Controlled Release. 2015;218:13-21.